Smeal Tod bought CRDF
April 14, 2026 · Form 4 insider transaction
Smeal Tod bought 300,000 shares of Cardiff Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
300,000
Price
$0.00
Total value
N/A
InsiderSmeal Tod
RoleOfficer
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateApril 14, 2026
Filing dateApril 16, 2026
Shares owned after1,279,805
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
75,000 vest on April 14, 2027 and 6,250 vest monthly for 36 months thereafter